PFE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 20:00):

Stats
Dagens volum	15.29M
Gjennomsnittsvolum	41.88M
Markedsverdi	145.23B
EPS	$0 ( 2024-01-30 )
Neste inntjeningsdato	( $0.560 ) 2024-05-01
Last Dividend	$0.410 ( 2023-11-09 )
Next Dividend	$0 ( N/A )
P/E	69.51
ATR14	$0.0140 (0.05%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-25	Quincey James	Buy	8 116	Phantom Stock Units
2024-04-25	Smith James C	Buy	8 116	Phantom Stock Units
2024-04-25	Nora Johnson Suzanne M	Buy	8 116	Phantom Stock Units
2024-04-25	Narayen Shantanu	Buy	8 116	Phantom Stock Units
2024-04-25	Littman Dan R.	Buy	8 116	Phantom Stock Units

INSIDER POWER
70.79
Last 100 transactions
Buy: 4 329 307 \| Sell: 745 543

Volum Korrelasjon

Lang: -0.25 (neutral)

Kort: -0.07 (neutral)

Signal:(38.221) Neutral

Pfizer Inc Korrelasjon

10 Mest positive korrelasjoner
PCQ	0.969
ZME	0.962
CHGG	0.951
RSF	0.947
GDMA	0.946
TPL	0.941
CALX	0.939
EVTL	0.937
PCK	0.936
K	0.93

10 Mest negative korrelasjoner
WWW	-0.954
HCI	-0.953
NGL-PB	-0.95
FSNB	-0.949
LOCC	-0.949
LHC	-0.948
VNT	-0.947
CRH	-0.945
FTAI	-0.942
JMP	-0.94

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Pfizer Inc Korrelasjon - Valuta/Råvare

-0.11
( neutral )

-0.18
( neutral )

0.00
( neutral )

0.44
( neutral )

0.59
( weak )

Pfizer Inc Økonomi

Annual	2023
Omsetning:	$58.50B
Bruttogevinst:	$29.28B (50.06 %)
EPS:	$0.380

FY	2023
Omsetning:	$58.50B
Bruttogevinst:	$29.28B (50.06 %)
EPS:	$0.380

FY	2022
Omsetning:	$100.33B
Bruttogevinst:	$65.99B (65.77 %)
EPS:	$5.59

FY	2021
Omsetning:	$81.29B
Bruttogevinst:	$50.47B (62.08 %)
EPS:	$3.92

Financial Reports:

No articles found.

Pfizer Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.400 (N/A)	$0.400 (N/A)	$0.410 (N/A)	$0.410 (N/A)	$0.410 (N/A)	$0.410 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Pfizer Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 6.10 - average (70.40%) | Divividend Growth Potential Score: 4.07 - Stable (18.61%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00316	1972-08-29
Last Dividend	$0.410	2023-11-09
Next Dividend	$0	N/A
Payout Date	2023-12-04
Next Payout Date	N/A
# dividends	206	--
Total Paid Out	$26.05	--
Avg. Dividend % Per Year	2.24%	--
Score	4.92	--
Div. Sustainability Score	6.10
Div.Growth Potential Score	4.07
Div. Directional Score	5.09	--

Next Divdend (Est)
(2024-07-01)

$0.413 Estimate 39.90 %

Dividend Stability

0.80 Good

Dividend Score

4.92

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1972	$0.00731	0.90%
1973	$0.0138	1.60%
1974	$0.0156	1.83%
1975	$0.0160	2.52%
1976	$0.0170	3.03%
1977	$0.0196	3.44%
1978	$0.0231	4.27%
1979	$0.0261	3.98%
1980	$0.0285	3.84%
1981	$0.0316	3.01%
1982	$0.0364	3.50%
1983	$0.0460	3.43%
1984	$0.0524	3.66%
1985	$0.0584	3.65%
1986	$0.0648	3.27%
1987	$0.0712	2.91%
1988	$0.0792	4.13%
1989	$0.0868	3.81%
1990	$0.0948	3.37%
1991	$0.104	3.29%
1992	$0.117	1.77%
1993	$0.133	2.32%
1994	$0.149	2.77%
1995	$0.164	2.74%
1996	$0.190	1.93%
1997	$0.215	1.66%
1998	$0.240	1.00%
1999	$0.291	0.75%
2000	$0.342	1.13%
2001	$0.416	0.95%
2002	$0.492	1.30%
2003	$0.568	1.90%
2004	$0.644	1.91%
2005	$0.720	2.87%
2006	$0.912	4.04%
2007	$1.100	4.41%
2008	$1.216	5.59%
2009	$0.760	4.39%
2010	$0.684	3.81%
2011	$0.760	4.53%
2012	$0.836	4.01%
2013	$0.912	3.71%
2014	$0.988	3.42%
2015	$1.064	3.58%
2016	$1.140	3.76%
2017	$1.216	3.88%
2018	$1.292	3.74%
2019	$1.368	3.33%
2020	$1.444	3.89%
2021	$1.560	4.24%
2022	$1.600	2.82%
2023	$1.640	3.20%
2024	$0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0364	1.500	9.27	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00941	1.200	9.69	10.00	[0 - 0.3]
returnOnEquityTTM	0.0221	1.500	-0.866	-1.298	[0.1 - 1]
payoutRatioTTM	4.34	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	0.907	0.800	-0.467	-0.373	[1 - 3]
quickRatioTTM	0.499	0.800	-1.768	-1.415	[0.8 - 2.5]
cashRatioTTM	0.0597	1.500	-0.779	-1.169	[0.2 - 2]
debtRatioTTM	0.320	-1.500	4.67	-7.01	[0 - 0.6]
interestCoverageTTM	1.631	1.000	-0.507	-0.507	[3 - 30]
operatingCashFlowPerShareTTM	1.541	2.00	9.49	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.849	2.00	9.58	10.00	[0 - 20]
debtEquityRatioTTM	0.814	-1.500	6.75	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.490	1.000	5.17	5.17	[0.2 - 0.8]
operatingProfitMarginTTM	0.0616	1.000	-0.768	-0.768	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.120	1.000	-0.444	-0.444	[0.2 - 2]
assetTurnoverTTM	0.258	0.800	-1.612	-1.289	[0.5 - 2]
Total Score				6.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	67.28	1.000	3.31	0	[1 - 100]
returnOnEquityTTM	0.0221	2.50	-0.556	-1.298	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.849	2.00	9.72	10.00	[0 - 30]
dividendYielPercentageTTM	6.50	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.541	2.00	9.49	10.00	[0 - 30]
payoutRatioTTM	4.34	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-1.438	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.149	1.000	8.78	0	[0.1 - 0.5]
Total Score				4.07

Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Sanntidsoppdatering for Pfizer Inc [PFE]

Upcoming Earnings Alert

Pfizer Inc Dividend Information - Dividend Knight

Dividend Commentary

Top 10 dividend Companies for NYSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)